Dr Reddys Laboratories (RDY) Shares Outstanding (Entity) (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.15 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 319.35 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 373.90 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 23.85 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 42.53 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 35.03 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 14.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 834.66 Mn |
| Mar 31, 2025 | 834.46 Mn |
| Mar 31, 2024 | 834.09 Mn |
| Mar 31, 2023 | 832.64 Mn |
| Mar 31, 2022 | 832.13 Mn |
| Mar 31, 2021 | 831.51 Mn |
| Mar 31, 2020 | 830.86 Mn |
| Mar 31, 2019 | 830.33 Mn |
| Mar 31, 2018 | 829.55 Mn |
| Mar 31, 2017 | 853.04 Mn |
| Mar 31, 2016 | 851.91 Mn |
| Mar 31, 2015 | 851.57 Mn |
| Mar 31, 2014 | 850.22 Mn |
| Mar 31, 2013 | 849.18 Mn |
| Mar 31, 2012 | 847.80 Mn |
| Mar 31, 2011 | 846.26 Mn |
| Mar 31, 2010 | 844.23 Mn |
| Mar 31, 2009 | 841.75 Mn |